Literature DB >> 33159306

Mesenchymal Stem Cells: The Past Present and Future.

Noha Attia1,2,3,4, Mohamed Mashal5,6.   

Abstract

The biomedical applications of mesenchymal stem cells (MSCs) have gained expanding attention over the past three decades. MSCs are easily obtained from various tissue types (e.g. bone marrow, fat, cord blood, etc.), are capable of self-renewal, and could be induced to differentiate into several cell lineages for countless biomedical applications. In addition, when transplanted, MSCs are not detected by immune surveillance, thus do not lead to graft rejection. Moreover, they can home towards affected tissues and induce their therapeutic effect in a cell-base and/or a cell-free manner. These properties, and many others, have made MSCs appealing therapeutic cell candidates (for cell and/or gene therapy) in myriad clinical conditions. However, similar to any other therapeutic tool, MSCs still have their own limitations and grey areas that entail more research for better understanding and optimization. Herein, we present a brief overview of various pre-clinical/clinical applications of MSCs in regenerative medicine and discuss limitations and future challenges.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  Drug delivery; Extracellular vesicles; Gene therapy; Mesenchymal stem cells; Secretome

Mesh:

Year:  2021        PMID: 33159306     DOI: 10.1007/5584_2020_595

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Insights into the potential role of alpha1-antitrypsin in COVID-19 patients: Mechanisms, current update, and future perspectives.

Authors:  Saber Marzouk; Noha Attia; Mohamed Mashal
Journal:  Clin Respir J       Date:  2021-07-12       Impact factor: 1.761

2.  Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.

Authors:  Duanfeng Jiang; Xin Wu; Xiaoying Sun; Wei Tan; Xin Dai; Youbang Xie; Ashuai Du; Qiangqiang Zhao
Journal:  J Nanobiotechnology       Date:  2022-01-10       Impact factor: 10.435

Review 3.  Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies.

Authors:  Noha Attia; Mohamed Mashal; Sudhakar Pemminati; Adekunle Omole; Carolyn Edmondson; Will Jones; Priyanka Priyadarshini; Temoria Mughal; Pauline Aziz; Blesing Zenick; Ambar Perez; Morgan Lacken
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

4.  Growth Hormone Receptor Controls Adipogenic Differentiation of Chicken Bone Marrow Mesenchymal Stem Cells by Affecting Mitochondrial Biogenesis and Mitochondrial Function.

Authors:  Changbin Zhao; Bowen Hu; Zhiying Liao; Haohui Wei; Yongxia Zhao; Jinping Liang; Wen Luo; Qinghua Nie; Qingbin Luo; Dexiang Zhang; Xiquan Zhang; Hongmei Li
Journal:  Front Cell Dev Biol       Date:  2022-03-08

Review 5.  Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy.

Authors:  María Cecilia Sanmartin; Francisco Raúl Borzone; María Belén Giorello; Gustavo Yannarelli; Norma Alejandra Chasseing
Journal:  Front Bioeng Biotechnol       Date:  2022-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.